Company Reports Q4 Revenue of $2.97B, ROE of 25.9%
Reports Q4 revenue $2.97B. Reports return on average common equity of 25.9% and operating return on average common equity of 18.2%. Reports bo0k value per common share $247.00 vs. $195.77 last year. The company said, "We are pleased to report that we grew book value per common share by 26.2% and tangible book value per common share plus change in accumulated dividends by 30.8% in 2025, and that each of these metrics has more than doubled over the last three years. We have accomplished this by consistently executing our strategy and maximizing the returns on each of our Three Drivers of Profit - underwriting, fee and net investment income - while optimizing our capital base through significant capital return to our investors. At the January 1 renewal, we retained the lines that we targeted and built an underwriting portfolio designed to generate returns well in excess of the cost of capital. Looking forward to 2026, we expect the combination of our attractive underwriting portfolio, strong fee and investment income and robust capital management will continue to generate long-term value for our shareholders."
Trade with 70% Backtested Accuracy
Analyst Views on RNR
About RNR
About the author


- Stock Sale Announcement: Officer Ross Curtis of Renaissance Re Holdings intends to sell 15,000 shares of its common stock.
- Market Value: The total market value of the shares being sold is approximately $4.43 million.
- Earnings Beat: RenaissanceRe reported a Q4 non-GAAP EPS of $13.34, surpassing expectations by $2.93, which reflects the company's strong profitability and boosts investor confidence.
- Significant Revenue Growth: The company achieved revenues of $2.97 billion in Q4, marking a 29.7% year-over-year increase and exceeding forecasts by $1.3 billion, indicating robust competitive positioning and business expansion capabilities.
- Undervalued Preferred Stocks: Market analysis suggests that RenaissanceRe's preferred stocks are undervalued, potentially offering investors a compelling opportunity, highlighting the company's advantages in capital structure.
- Positive Future Outlook: With ongoing growth in the insurance and reinsurance markets, analysts maintain an optimistic outlook for RenaissanceRe's future performance, which is expected to further enhance shareholder returns and market share.
- Earnings Release Date: RenaissanceRe is set to announce its Q4 earnings on February 3rd after market close, with a consensus EPS estimate of $10.41, reflecting a 29.2% year-over-year growth, indicating sustained profitability.
- Revenue Expectations Decline: Despite the optimistic EPS outlook, the revenue estimate stands at $1.67 billion, representing a 27.1% year-over-year decline, highlighting potential challenges in the market environment and business fluctuations.
- Historical Performance: Over the past two years, RenaissanceRe has beaten EPS estimates 88% of the time and revenue estimates 63% of the time, demonstrating the company's reliability in earnings forecasts and market confidence.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen 14 upward revisions and 1 downward revision, while revenue estimates have had 1 upward revision with no downward adjustments, reflecting analysts' optimistic outlook on the company's future performance.

- RenaissanceRe Earnings Surge: RenaissanceRe Holdings Ltd. has seen its current year earnings estimate rise by 27.4% over the last 60 days, indicating robust performance in the insurance and reinsurance sector, which is likely to drive stock price appreciation and bolster market confidence.
- Phibro's Performance Boost: Phibro Animal Health Corporation's earnings estimate has increased by 9.1% in the past 60 days, with a PEG ratio of 1.07, significantly lower than the industry average of 2.68, highlighting the company's competitive edge and growth potential in the animal health sector.
- Commercial Metals Growth Outlook: Commercial Metals Company has experienced a 21.3% increase in its current year earnings estimate over the last 60 days, with a PEG ratio of 0.39, showcasing strong growth potential in the steel and metals manufacturing industry, likely attracting more investor interest.
- Investment Opportunities: Zacks Investment Research anticipates the release of 10 top stock picks for 2026, with historical performance suggesting they could significantly outperform the S&P 500, prompting investors to keep an eye on these high-return opportunities.
- Earnings Estimate Increase: RenaissanceRe Holdings Ltd. has seen its 2023 earnings estimate raised by 27.6% over the past 60 days, indicating strong performance in the insurance and reinsurance sectors, which is expected to drive stock price appreciation and bolster investor confidence.
- Industry Competitiveness: The company's PEG ratio stands at 1.61, lower than the industry average of 1.81, highlighting its relatively high growth potential, which may attract more investor interest and enhance its market position.
- Growth Score: With a Growth Score of B, RenaissanceRe is recognized for its growth potential within the industry, likely appealing to investors seeking stable returns and further driving capital inflows.
- Market Opportunity: As demand for insurance and reinsurance rises, the upward revision of RenaissanceRe's earnings estimates may enable it to capture a larger share in a competitive market, facilitating sustainable growth.

Market Overview: The U.S. economy is experiencing challenges such as persistent inflation and declining job growth, prompting the Federal Reserve to cut interest rates for the third time this year, complicating stock market interpretations for retail investors.
Sales Growth as a Metric: Focusing on sales growth rather than earnings is recommended for stock evaluation, as it provides a clearer picture of a company's business momentum and potential for future earnings improvement.
Highlighted Stocks: Five stocks with strong sales growth potential are identified: Vertiv Holdings Co (27.5% expected growth), RenaissanceRe Holdings Ltd (3.4%), Ameren Corp (17.7%), Canadian Natural Resources Ltd (5.9%), and FedEx Corp (4.6%).
Investment Tools: Zacks Investment Research offers the Research Wizard, a user-friendly stock picking and backtesting software, to help investors identify promising stocks based on sales growth and other metrics.







